Effect of sarcopenia on short-term and long-term outcomes of older patients with locally advanced gastric cancer: a multicenter study
- PMID: 38082017
- DOI: 10.1007/s00464-023-10638-1
Effect of sarcopenia on short-term and long-term outcomes of older patients with locally advanced gastric cancer: a multicenter study
Abstract
Objective: To assess the effect of preoperative sarcopenia on the short-term and long-term outcomes in older patients with locally advanced gastric cancer (LAGC).
Methods: Clinicopathological data of older patients with LAGC who underwent radical surgery were retrospectively analyzed. Sarcopenia was defined as a skeletal muscle index of less than 36.4 cm2/m2 for men and less than 28.4 cm2/m2 for women. Comparing the postoperative complications and survival between sarcopenia and non-sarcopenia groups using multicenter data.
Results: A total of 406 older patients with LAGC were included in the analysis, including 145 (35.7%) with sarcopenia and 261 (64.3%) with non-sarcopenia. Multivariate logistic regression analysis showed that sarcopenia was an independent risk factor for postoperative complications with CD grade ≥ II (OR 1.616; P < 0.05). Kaplan-Meier survival curve analysis showed that the 5-year overall survival (OS) and 5-year recurrence-free survival (RFS) in the sarcopenia group were lower than those in the non-sarcopenia group (P both < 0.05). Multivariate Cox regression analyses showed that sarcopenia was an independent prognostic factor for 5-year OS and RFS (P both < 0.05). The 5-year recurrence rate in the sarcopenia group was 57.2%, which was significantly higher than that in the non-sarcopenia group (46.4%; P = 0.036). Recurrence pattern analysis showed that the incidence of distant metastases in patients with sarcopenia (42.8%) was significantly higher than non-sarcopenia (31.4%; P = 0.022).
Conclusion: Sarcopenia serves as a valuable predictor of both short-term and long-term outcomes in older patients with LAGC. Therefore, the significance of assessing preoperative nutritional status and implementing thorough postoperative follow-up for older LAGC patients with sarcopenia should be emphasized.
Keywords: Complications; Locally advanced gastric cancer; Older patients; Prognosis; Sarcopenia.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Textbook oncological outcome of locally advanced gastric cancer patients with preoperative sarcopenia: a multicenter clinical study.Surg Endosc. 2025 Jan;39(1):356-367. doi: 10.1007/s00464-024-11397-3. Epub 2024 Nov 15. Surg Endosc. 2025. PMID: 39548007
-
Preoperative sarcopenia and postoperative accelerated muscle loss negatively impact survival after resection of locally advanced gastric cancer.BMC Cancer. 2025 Feb 14;25(1):269. doi: 10.1186/s12885-025-13674-3. BMC Cancer. 2025. PMID: 39953409 Free PMC article.
-
Prognostic value of preoperative sarcopenia in gastric cancer: A 10-year follow-up study.Eur J Surg Oncol. 2024 Mar;50(3):108004. doi: 10.1016/j.ejso.2024.108004. Epub 2024 Feb 3. Eur J Surg Oncol. 2024. PMID: 38330540
-
Predictive Value of Preoperative Sarcopenia in Patients with Gastric Cancer: a Meta-analysis and Systematic Review.J Gastrointest Surg. 2018 Nov;22(11):1890-1902. doi: 10.1007/s11605-018-3856-0. Epub 2018 Jul 9. J Gastrointest Surg. 2018. PMID: 29987739
-
Effect of omentum preservation on long-term prognosis of locally advanced gastric cancer: a systematic review and meta-analysis.World J Surg Oncol. 2024 Sep 6;22(1):236. doi: 10.1186/s12957-024-03521-3. World J Surg Oncol. 2024. PMID: 39243034 Free PMC article.
Cited by
-
Preoperative albumin-bilirubin grade combined with sarcopenia predicts long-term outcomes after laparoscopic gastrectomy for advanced gastric cancer.BMC Gastroenterol. 2025 Aug 1;25(1):550. doi: 10.1186/s12876-025-04173-7. BMC Gastroenterol. 2025. PMID: 40751126 Free PMC article.
-
Textbook oncological outcome of locally advanced gastric cancer patients with preoperative sarcopenia: a multicenter clinical study.Surg Endosc. 2025 Jan;39(1):356-367. doi: 10.1007/s00464-024-11397-3. Epub 2024 Nov 15. Surg Endosc. 2025. PMID: 39548007
-
Large Unstained Cells: A Predictive Biomarker for Recurrence and Survival in Resected Gastric Cancer.Medicina (Kaunas). 2025 Jan 24;61(2):208. doi: 10.3390/medicina61020208. Medicina (Kaunas). 2025. PMID: 40005326 Free PMC article.
-
Prognostic relevance of sarcopenia and tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma.Ann Gastroenterol Surg. 2024 Oct 26;9(2):359-368. doi: 10.1002/ags3.12875. eCollection 2025 Mar. Ann Gastroenterol Surg. 2024. PMID: 40046516 Free PMC article.
References
-
- Fock KM (2014) Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther 40:250–260 - PubMed
-
- Marano L, Polom K, Patriti A et al (2016) Surgical management of advanced gastric cancer: an evolving issue. Eur J Surg Oncol 42:18–27 - PubMed
-
- Visa L, Jimenez-Fonseca P, Martinez EA et al (2018) Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: a real-world data, non-inferiority analysis. J Geriatr Oncol 9:254–264 - PubMed
-
- Huang DD, Yu DY, Song HN et al (2021) The relationship between the GLIM-defined malnutrition, body composition and functional parameters, and clinical outcomes in elderly patients undergoing radical gastrectomy for gastric cancer. Eur J Surg Oncol 47:2323–2331 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical